Aligned Genetics, Novartis Secures Initial Order of $400K for 'LUNA-FX7'

Resumen del corpus

Aligned Genetics secured an initial order of $400,000 for its automated cell analysis system, 'LUNA-FX7', from Novartis. This follows their selection as a Preferred Supplier, marking 4% of the previous year's sales. The initial equipment supply will be delivered to three Novartis facilities in Switzerland, Boston, and San Diego, USA. The system is used in biopharmaceutical R&D and quality control for cell therapy drugs, with plans to expand supply to other Novartis sites.